Aurora Cannabis PE Ratio 2017-2025 | ACB
Current and historical p/e ratio for Aurora Cannabis (ACB) from 2017 to 2025. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Aurora Cannabis PE ratio as of November 07, 2025 is 145.33.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Aurora Cannabis PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2025-11-07 | 4.55 | 0.00 | |
| 2025-09-30 | 5.96 | $-0.03 | 0.00 |
| 2025-06-30 | 4.24 | $-0.19 | 0.00 |
| 2025-03-31 | 4.39 | $0.11 | 39.91 |
| 2024-12-31 | 4.25 | $0.05 | 85.00 |
| 2024-09-30 | 5.88 | $-0.76 | 0.00 |
| 2024-06-30 | 4.62 | $-0.70 | 0.00 |
| 2024-03-31 | 4.39 | $-1.40 | 0.00 |
| 2023-12-31 | 4.76 | $-2.60 | 0.00 |
| 2023-09-30 | 5.85 | $-3.50 | 0.00 |
| 2023-06-30 | 5.35 | $-40.70 | 0.00 |
| 2022-12-31 | 9.23 | $-43.10 | 0.00 |
| 2022-09-30 | 12.20 | $-42.10 | 0.00 |
| 2022-03-31 | 40.00 | $-47.50 | 0.00 |
| 2021-12-31 | 54.10 | $-23.60 | 0.00 |
| 2021-09-30 | 69.20 | $-27.50 | 0.00 |
| 2021-03-31 | 93.10 | $-37.20 | 0.00 |
| 2020-12-31 | 83.10 | $-137.34 | 0.00 |
| 2020-09-30 | 46.50 | $-122.74 | 0.00 |
| 2020-03-31 | 108.72 | $-130.25 | 0.00 |
| 2019-12-31 | 259.20 | $-142.86 | 0.00 |
| 2019-09-30 | 526.80 | $-25.21 | 0.00 |
| 2019-03-31 | 1087.20 | $-26.41 | 0.00 |
| 2018-12-31 | 595.20 | $-15.61 | 0.00 |
| 2018-09-30 | 1152.00 | $8.40 | 137.09 |
| 2018-06-30 | 818.13 | $-1.20 | 0.00 |
| 2018-03-31 | 841.27 | $-2.40 | 0.00 |
| 2017-12-31 | 882.93 | $1.20 | 735.47 |
| 2017-09-30 | 258.05 | $-1.20 | 0.00 |
| 2017-06-30 | 193.13 | $-4.80 | 0.00 |
| 2017-03-31 | 225.07 | $-8.40 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.245B | $0.247B |
| Aurora Cannabis Inc is a Canada-based company engaged in the production and distribution of medical cannabis. The Company is vertically integrated and horizontally diversified across every key segment of the value chain, from facility engineering and design to cannabis breeding and genetics research, cannabis and hemp production, derivatives, home cultivation, wholesale and retail distribution. The Company's purpose-built facilities, which integrate technologies across all processes, are defined by automation and customization. The Company has a funded capacity of more than 500,000 kilograms per year, as well as sales and operations in 24 countries across 5 continents. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $217.272B | 25.04 |
| EssilorLuxottica (ESLOY) | France | $167.297B | 0.00 |
| Boston Scientific (BSX) | United States | $146.836B | 33.58 |
| Stryker (SYK) | United States | $135.305B | 26.86 |
| Medtronic (MDT) | Ireland | $115.519B | 16.29 |
| Lonza Group Ag (LZAGY) | Switzerland | $46.274B | 0.00 |
| Agilent Technologies (A) | United States | $41.813B | 27.06 |
| ResMed (RMD) | United States | $36.434B | 25.22 |
| GE HealthCare Technologies (GEHC) | United States | $33.786B | 16.16 |
| Koninklijke Philips (PHG) | Netherlands | $27.193B | 17.76 |
| Terumo (TRUMY) | Japan | $23.733B | 28.12 |
| Insulet (PODD) | United States | $22.765B | 70.61 |
| Zimmer Biomet Holdings (ZBH) | United States | $17.541B | 10.94 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.850B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $11.495B | 0.00 |
| Baxter (BAX) | United States | $9.243B | 7.46 |
| Bio-Rad Laboratories (BIO) | United States | $8.296B | 29.73 |
| Demant (WILYY) | Denmark | $7.359B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $3.651B | 10.85 |
| Haemonetics (HAE) | United States | $3.233B | 13.98 |
| Envista Holdings (NVST) | United States | $3.203B | 18.38 |
| ICU Medical (ICUI) | United States | $3.201B | 20.32 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.120B | 0.00 |
| Prestige Consumer Healthcare (PBH) | United States | $3.020B | 13.46 |
| Perrigo (PRGO) | Ireland | $2.055B | 5.15 |
| LeMaitre Vascular (LMAT) | United States | $1.938B | 39.09 |
| Phibro Animal Health (PAHC) | United States | $1.745B | 17.42 |
| Curaleaf Holdings (CURLF) | Canada | $1.634B | 0.00 |
| AtriCure (ATRC) | United States | $1.566B | 0.00 |
| QuidelOrtho (QDEL) | United States | $1.444B | 9.28 |
| Tilray Brands (TLRY) | Canada | $1.359B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.350B | 59.18 |
| Kestra Medical Technologies (KMTS) | United States | $1.343B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.300B | 18.84 |
| Neogen (NEOG) | United States | $1.299B | 24.92 |
| BioLife Solutions (BLFS) | United States | $1.294B | 386.00 |
| InMode (INMD) | Israel | $0.913B | 10.31 |
| Valneva SE (VALN) | France | $0.765B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.738B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.493B | 16.99 |
| Evolus (EOLS) | United States | $0.465B | 0.00 |
| SNDL (SNDL) | Canada | $0.462B | 0.00 |
| Omeros (OMER) | United States | $0.448B | 0.00 |
| CeriBell (CBLL) | United States | $0.429B | 0.00 |
| Surmodics (SRDX) | United States | $0.378B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.356B | 0.00 |
| Brainsway (BWAY) | Israel | $0.296B | 59.96 |
| Capricor Therapeutics (CAPR) | United States | $0.287B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.286B | 0.00 |
| Cerus (CERS) | United States | $0.270B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.261B | 0.00 |
| High Tide (HITI) | Canada | $0.253B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.248B | 0.00 |
| Owens & Minor (OMI) | United States | $0.241B | 2.42 |
| Viemed Healthcare (VMD) | United States | $0.238B | 18.97 |
| Exagen (XGN) | United States | $0.235B | 0.00 |
| Quanterix (QTRX) | United States | $0.232B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.226B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.219B | 0.00 |
| Organigram Global (OGI) | Canada | $0.199B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.189B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.186B | 16.35 |
| TerrAscend (TSNDF) | Canada | $0.181B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.176B | 21.68 |
| OraSure Technologies (OSUR) | United States | $0.172B | 0.00 |
| Biote (BTMD) | United States | $0.140B | 5.68 |
| Apyx Medical (APYX) | United States | $0.127B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.108B | 0.00 |
| Sharps Technology (STSS) | United States | $0.107B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.099B | 0.00 |
| Fonar (FONR) | United States | $0.092B | 12.01 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.090B | 0.00 |
| MacroGenics (MGNX) | United States | $0.086B | 0.00 |
| Agape ATP (ATPC) | $0.062B | 0.00 | |
| ImmuCell (ICCC) | United States | $0.057B | 33.21 |
| Nephros (NEPH) | United States | $0.055B | 40.00 |
| Cytosorbents (CTSO) | United States | $0.045B | 0.00 |
| Jin Medical (ZJYL) | China | $0.041B | 0.00 |
| Veru (VERU) | United States | $0.037B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.035B | 0.00 |
| Bonk (BNKK) | United States | $0.033B | 0.00 |
| Zynex (ZYXI) | United States | $0.032B | 0.00 |
| United-Guardian (UG) | United States | $0.030B | 15.26 |
| Modular Medical (MODD) | United States | $0.028B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.013B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.011B | 0.00 |
| INLIF (INLF) | China | $0.011B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.007B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.007B | 0.00 |
| Flora Growth (FLGC) | United States | $0.006B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.005B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.005B | 0.00 |
| Akanda (AKAN) | Canada | $0.001B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |